Cargando…
Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson’s Disease
Parkinson’s disease (PD) pathology involves progressive degeneration and death of vulnerable dopamine neurons in the substantia nigra. Extensive axonal arborization and distinct functions make this type of neurons particularly sensitive to homeostatic perturbations, such as protein misfolding and Ca...
Autores principales: | Kovaleva, Vera, Saarma, Mart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543257/ https://www.ncbi.nlm.nih.gov/pubmed/34180421 http://dx.doi.org/10.3233/JPD-212673 |
Ejemplares similares
-
Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease
por: Wang, Danni, et al.
Publicado: (2023) -
The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson’s Disease Physiopathology
por: da Costa, Cristine Alves, et al.
Publicado: (2020) -
CDNF Protein Therapy in Parkinson’s Disease
por: Huttunen, Henri J., et al.
Publicado: (2019) -
Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis
por: Ke, Ben, et al.
Publicado: (2017) -
Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer’s and Parkinson’s Disease
por: Nomura, Jun, et al.
Publicado: (2016)